Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Mechanisms of remyelination: recent insight from experimental models.
2010 McDonald criteria in a pediatric cohort: is positivity at onset associated with a more aggressive multiple sclerosis course?
Molecular approach to targeted therapy for multiple sclerosis.
Demyelinating disease: CSF analysis could aid prediction of conversion from optic neuritis to multiple sclerosis in children.
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance.
A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology.
Cytokines as Biomarkers of Treatment Response to IFN β in Relapsing-Remitting Multiple Sclerosis.
Brain MRI lesions and atrophy are associated with employment status in patients with multiple sclerosis.
Local assessment of myelin health in a multiple sclerosis mouse model using a 2D Fourier transform approach.
Neuroinflammation: no rose by any other name.
Adrenergic regulation of innate immunity: a review.
Multimodal neurophysiological evaluation of primary progressive multiple sclerosis - An increasingly valid biomarker, with limits.
Albumin heterogeneity in low-abundance fluids. The case of urine and cerebro-spinal fluid.
Involvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis.
Increased prevalence of lymphoid tissue inducer cells in the cerebrospinal fluid of patients with early multiple sclerosis.
Clobetasol and Halcinonide Act as Smoothened Agonists to Promote Myelin Gene Expression and RxRγ Receptor Activation.
The coexistence of multiple sclerosis and hereditary spastic paraparesis in a patient.
MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis.
Use and users of complementary and alternative medicine among people with multiple sclerosis in Denmark.
Increasing consistency of disease biomarker prediction across datasets.
Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis.
The New England Journal of Medicine publishes pivotal data demonstrating efficacy and safety of oral BG-12 (dimethyl fumarate) in multiple sclerosis.
Interferon-stimulated genes-essential antiviral effectors implicated in resistance to Theiler's virus-induced demyelinating disease.
Deep grey matter involvement in multiple sclerosis: key player or bystander?
Validation of the World Health Organization Disability Assessment Schedule II (WHODAS-II) in patients with multiple sclerosis.
Pages
« first
‹ previous
…
511
512
513
514
515
516
517
518
519
…
next ›
last »